Fundraising Fox

Cedilla Therapeutics, Inc.

Cambridge, US · Founded 2017 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

AG
Alexandra GlucksmannNamed on SEC filing
DN
Dominik NaczynskiNamed on SEC filing
CB
Chris BowdenNamed on SEC filing
JS
Jake SimsonNamed on SEC filing
RK
Rosana KapellerNamed on SEC filing

Board

ACAbbie Celniker
Abbie CelnikerinBoard directorInvestor at Third Rock Ventures
ECEli Casdin
Eli Casdinin𝕏Board directorChief Investment Officer and Founder at Casdin Capital
NENeil Exter
Neil ExterinBoard directorRetired Partner at Third Rock Ventures

Investors · 2

Casdin CapitalreportedNew Yorkvia Eli Casdin · board
Third Rock VenturesreportedBoston · $100K – $5Mvia Abbie Celniker · board

Reported raises · per SEC filings

Form D private placements

$82.6M disclosed across 1 round · 2020

▶$82.6MraisedOct 2021 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Abbie CelnikerDirector
  • Alexandra GlucksmannExecutive Officer, Director
  • Dominik NaczynskiDirector
  • Eli CasdinDirector
  • Chris BowdenDirector
  • Neil ExterDirector
  • Jake SimsonDirector
  • Rosana KapellerDirector
Offering amount
$82.6M
Amount sold
$82.6M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Cedilla Therapeutics, Inc.'s investors?
Cedilla Therapeutics, Inc.'s investors include Casdin Capital, Third Rock Ventures.
How much funding has Cedilla Therapeutics, Inc. raised?
Cedilla Therapeutics, Inc. has disclosed $82.6M raised across 1 round.
Where is Cedilla Therapeutics, Inc. headquartered?
Cedilla Therapeutics, Inc. is headquartered in Cambridge, US.